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Background/Aims  :  Continuous  renal  replacement  therapy  (CRRT)  has  been  widely  used  for  treating  critically  ill 
patients with acute kidney injury (AKI).  Whether  CRRT is better than intermittent  hemodialysis for the  treatment of  AKI 
remains controversial. We sought to identify the clinical features that can predict survival for the patients who are treated 
with  CRRT.
Methods :  We  analyzed  the  data  of  125  patients  who  received  CRRT  between  2005  and  2007.  We  identified  the 
demographic variables, the underlying diagnoses, the duration of CRRT, the mean arterial blood pressure (ABP) and the 
Simplified Acute Physiology Score (SAPS) II. The classification/stagi ng system for acute kidney inj ury ( AKI)  was appl ied 
to  all  the  patients,  who  were  then  divided  into  stage  1-3  subgroups.
Results : The average age of the patients was 61.414.3 years and the mortality rate was 60% (75 of 125 patients). 
The survivors had a significantly higher mean ABP and a higher mean serum bicarbonate level, which were measured 
the  day  after  CRRT,  than  the  nonsurvivors  (86.723.7  vs. 69.224.6  mm H g,  r e s p e c t i v e l y ,  21 . 43 . 5 v s .  1 6. 4 5. 4  mmol / L ,  
respectively,; p<0.05 for each). The stage 3 AKI patients showed the worst parameters for the SAPS II score and the 
serum  levels  of  creatinine  and  blood  urea  nitrogen.  The  mortalit y  r a t e  w a s  h i g h e r  f o r  t h e  s t a g e  3  s u b g r o u p  t h a n  t h e  
other  groups  (70.5%,  p<0.05).
Conclusions : The patients with AKI and who require CRRT continue to have a  high mortality rate.  A  higher mean 
ABP and a higher serum bicarbonate level measured the day after CRRT may predict a more favorable prognosis. The 
staging  system  for  AKI  can  improve  the  ability  to  predict  the  outcomes  of  CRRT  patients.
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INTRODUCTION
Acute  kidney  injury  (AKI)  is  a  clinical  disorder  that  has  an 
extremely high mortality rate, and the cases that are induced by 
septicemia or multiorgan failure syndrome show poor outcomes. 
Although  the  mortality  rate  of  AKI  has  been  reduced  since  the 
use of renal replacement therapy (RRT) for patients with AKI, its 
mortality  rate  is  still  reported  to  be  as  high  as  40～70%. 
Intermittent  hemodialysis  (IDH)  has  the  disadvantage  in  that  it 
cannot successfully treat AKI due to the hypotension that occurs 
during  dialysis.  Since  continuous  renal  replacement  therapy 
(CRRT)  has  the  advantage  of  removing  the  solute  slowly  and 
continuously, it has been primarily used for treating AKI patients 
with  an  unstable  hemodynamic  status  or  the  AKI  is  associated 
with  multiorgan  failure  syndrome
1-4).  However,  although  CRRT 
has  many  advantages,  previous  studies  have  reported  that Woo  Kyun  Bae,  et  al  :  Continuous  RRT  in  AKI 59
C R R T  h a s  n o t  r e d u c e d  t h e  m o r t a l i t y  r a t e  a n y  m o r e  t h a n  
intermittent RRT
5, 6). Although AKI itself may contribute to its high 
mortality  rate,  there  is  the  possibility  that  RRT  can  further 
increase  the  mortality  rate.
Thus,  the  present  study  was  conducted  to  determine  the 
important factors that are related to the mortality rate of patients 
who  undergo  CRRT.
MATERIALS AND METHODS
Patients
This study included 125 patients who underwent CRRT at the 
Chonnam  National  University  Hospital  between  October  2005 
and May 2007. We retrospectively reviewed the patients' medical 
records in terms of age, gender, underlying diseases, treatment 
outcomes,  accompanying  diseases  and  the  mortality  rate.  We 
also  investigated  differences  in  the  aforementioned  clinical 
variables  between  the  study  groups  that  were  categorized 
according to the classification/staging system of AKI, as well as 
the  severity  of  the  accompanying  diseases.
Methods
The data on the vital signs and laboratory findings, including 
the serum levels of urea nitrogen, creatinine, albumin, electrolytes 
and  C-reactive  protein,  the  causes  of  AKI  and  the  presence  of 
oliguria were collected immediately before the start of CRRT. The 
disease severity of the patients undergoing CRRT was assessed 
using  the  Simplified  Acute  Physiology  Score  (SAPS)  II  system
7). 
CRRT  was  performed  with  a  computerized,  automated 
hemodialyzer  (Prisma,  Gambro,  Sweden).  The  venous  route  for 
RRT  was  established  with  a  double-lumen  catheter  that  was 
inserted  through  a  venovenous  access  puncture  through  the 
femoral  and  interval  jugular  veins.  Anticoagulant  therapy  was 
carried  out  with  heparin  and  using  an  AN69  filter  (a  copolymer 
o f  a c r y l o n i t r i l e  a n d  a n  s o d i u m  m e t h a l l y l s u l p h o n a t e  f i b r o u s  
membrane) in the patients with AKI, except for those who were 
contraindicated  for  the  therapy.  The  indications,  duration  of 
admission  until  the  initiation  of  RRT,  the  amount  of  ultrafiltrate, 
the blood flow rate, the duration of RRT, the use of heparin and 
the  complications  were  analyzed.  In  cases  where  patients  with 
AKI died during RRT, the time point of death was defined as the 
end  point  of  RRT.  Filters  were  replaced  only  when  they  were 
occluded  and  did  not  function  properly.  The  patients  were 
divided into 2 groups: the survivor and nonsurvivor groups. We 
compared  the  amount  of  electrolytes,  the  kidney  functions,  the 
mean arterial blood pressure (ABP), the SAPS II scores and the 
blood flow rate before and after continuous RRT between the 2 
groups.  We  also  analyzed  the  data  on  the  serum  levels  of 
electrolytes, creatinine and bicarbonate, and the mean ABP that 
was  measured  on  the  day  after  continuous  RRT.  In  addition, 
after  excluding  7  patients  who  underwent  RRT  such  as 
peritoneal  dialysis  or  hemodialysis,  118  subjects  were  divided 
into  3  subgroups  according  to  the  serum  creatinine  and  urine 
output: the stage 1 AKI subgroup that had an increase in serum 
creatinine  of  =0.3  mg/dL  or  an  increase  of  200～300%  above 
baseline and a urine output of <0.5 mL/kg/h for >6 h, the stage 
2  AKI  subgroup  that  had  an  increase  in  serum  creatinine  of 
>200～300%  above  baseline  and  a  urine  output  of  <0.5 
mL/kg/h  for  >12  h  and  the  stage  3  AKI  subgroup that  had an 
increase  of  serum  creatinine  of  >300%  above  baseline  or  a 
serum creatinine of =4 mg dL with an acute rise of =0.5 mg/dL 
and 0.3 mL/kg/h for >24 h or anuria for >12 h
8).
  The mortality 
rates were compared between the 3 subgroups, and the serum 
electrolyte  levels,  the  mean  ABP  and  the  outcomes  of  dialysis 
were  assessed  for  the  3  subgroups.
Statistical  analysis
The  data  was  expressed  as  means  SDs.  Statistical 
comparisons  were  made  between  the  survivor  and  nonsurvivor 
groups using the independent t-test, and statistical comparisons 
b e t w e e n  t h e  3  s u b g r o u p s  w e r e  d on e  u s i n g  t h e  c h i - s q u a r e  t e s t  
and  the  one-way  ANOVA  test.  The  contributory  factors  for  the 
mortality  rate  were  analyzed  using  logistic  regression  analysis. 
The survival rate was calculated using the Kaplan-Meier method. 
A  p  value  of  <0.05  was  considered  statistically  significant.  All 
s t a t i s t i c a l  a n a l y s e s  w e r e  p e r f o r m e d  u s i n g  S P S S  f o r  W i n d o w s  
12.0  (SPSS  Inc,  Chicago,  IL,  USA).
RESULTS
A  total  of  125  patients  received  RRT.  The  mean  age  of  the 
patients  was  61.4  (14.3)  years.  There  were  55  males  (44.0%) 
and  70  females  (56.0%).  Medical  diseases  (n=91,  72.8%)  were 
the  most  common  cause  of  AKI,  followed  by  surgical  diseases 
(n=29, 23.2%) and trauma (n=5,  4.0%). Oliguria  occurred in  84 
(67.2%) patients and septicemia occurred in 48 (38.4%) patients 
who underwent RRT. The mean SAPS II score was 60.5±16.3 
(Table  1).
The  most  common  indication  for  CRRT  was  hemodynamic 
instability  (n=88,  70.4%),  followed  by  cardiogenic  shock  (n=23, 
18.4%)  and  acute  respiratory  failure  (n=13,  10.4%).  The  mean 
t i m e  l a p s e  b e t w e e n  a d m i s s i o n  a n d  t h e  s t a r t  o f  R R T  w a s  
7.3±11.1  days  and  the  mean  duration  of  RRT  was  4.8±4.5 
days.  The  mean  amount  of  ultrafiltrate  was  956.8±180.7  mL/h 
and  heparin  was  used  in  29  (23.2%)  patients.  Complications 
occurred  in  33  (23.2%)  patients  after  RRT.  The  use  of  filters  2 
or  more  times  per  day  (n=26,  22.0%)  was  the  most  common 
complication,  followed  by  bleeding  (n=3,  2.5%)  and  catheter- The  Korean  Journal  of  Internal  Medicine  :  Vol.  23,  No.  2,  June  2008 60
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Demography
    Age  (years) 61.4±14.3
    Gender  (F/M) 70  (56.0%)/55  (44.0%)
Causes  of  acute  renal  failure
    Surgical 29  (23.2%)
    Medical 91  (72.8%)
    Trauma 5  (4.0%)
Clinical  characteristis
    SAPS  score 60.5±16.3
    Mean  blood  pressure(mmHg) 76.9±18.6
    Presence  of  sepsis 48  (38.4%)
    Oliguria 84  (67.2%)
    BUN  (mg/dL) 69.2±39.3
    Creatinine(mg/dL) 4.5±2.6
    Albumin  (g/dL) 2.8±0.6
    Hemoglobin  (g/dL) 9.8±2.25
    CRP  (mg/dL) 13.6±10.2
  H C O 3
-  (mmol/L) 17.0±5.2
S A P S ,  s i m p l i f i e d  a c u t e  p h y s i o l o g y  s c o r e ;  B U N ,  b l o o d  u r e a  
nitrogen;  CRP,  C-reactive  protein
Table  1.  Characteristics  of  the  patients  treated  with  continuous  renal 
replacement  therapy
Survivors  (n=50) Nonsurvivors  (n=75) p-value
Age
Gender  (female)
Presence  of  sepsis
SAPS  II  score
M e a n  b l o o d  p r e s s u r e  ( m m H g )
Albumin  (g/dL)
CRP  (mg/dL)
CRRT  parameters
    Mean  time  from  admission  to  CRRT
    Mean  delivered  ultrafiltration  (mL/24hr)
  M e a n  d u r a t i o n  o f  r e p l a c e m e n t  ( d a y s )
  M e a n  b l o o d  p r e s s u r e  ( m m H g )  1  d a y  a f t e r  C R R T
    HCO3
-  ( m m o l / L )  1  d a y  a f t e r  C R R T
61.1±13.2
25  (50%)
19  (38%)
58.0±16.4
82.9±19.0
3.0±0.5
12.1±10.8
5.8±7.7
943.4±166.3
4.6±3.6
86.7±23.7
21.4±3.5
61.7±15.0
30  (40%)
29  (38.7%)
62.2±16.2
73.0±17.4
2.7±0.6
14.6±9.7
8.4±12.8
966.0±190.6
4.8±5.0
69.2±24.6
16.4±5.4
NS
NS
NS
NS
p<0.05
p<0.05
NS
NS
NS
NS
p<0.05
p<0.05
SAPS,  simplified  acute  physiology  score;  CRP,  C-reactive  protein;  CRRT,  continuous  renal  replacement  therapy
Table  2.  Comparisons  between  the  survivors  and  nonsurvivors
related  infections  (n=3,  2.5%).
Of  the  patients  who  underwent  CRRT,  50  (40%)  survived. 
Table  2  shows  the  clinical  characteristics,  laboratory  data  and 
changes after RRT between the survivor (n=50) and nonsurvivor 
(n=75) groups. There was no significant differences in the causes 
o f  A K I  b e t w e e n  t h e  2  g r o u p s  ( p=0.875),  including  septicemia, 
hepatic  failure,  congestive  heart  failure  and  acute  respiratory 
distress syndrome. The mean SAPS II score was higher for the 
nonsurvivor  group  (62.2±16.2)  than  for  the  survivor  group 
(58.0±16.4),  but  the  difference  was  statistically  insignificant. 
Septicemia  occurred  in  19  (38%)  patients  of  the  survivor  group 
and  in  29  (38.7%)  patients  of  the  nonsurvivor  group,  but  the 
difference  was  statistically  insignificant.  The  mean  ABP  before 
the start of RRT was significantly lower for the nonsurvivor group 
than  for  the  survivor  group  (73.0±17.4  mm  Hg  vs.  82.9±19.0 
mm Hg, respectively; p<0.05). The mean ABP measured the day 
after RRT was significantly lower for the nonsurvivor group than 
for  the  survivor  group  (69.2±24.6  mm  Hg  vs  86.7±23.7  mm 
Hg,  respectively;  p<0.05).  The  serum  albumin  level  was 
significantly lower for the nonsurvivor group than for the survivor 
group  (2.7±0.6  g/dL  vs.  3.0±0.5  g/dL,  respectively;  p<0.05). 
The serum C-reactive protein level was higher for the nonsurvivor 
group (14.6±9.7 mg/dL) than for the survivor group (12.1±10.8 
mg/dL),  but  the  difference  was  statistically  insignificant.
There  were  no  significant  differences  between  the  2  groups 
for the blood flow rate, the amount of ultrafiltrate, the duration of 
dialysis  and  the  use  of  heparin.  The  mean  time  lapse  between 
a d m i s s i o n  a n d  t h e  s t a r t  o f  R R T  w a s  8 . 4 ± 1 2 . 8  d a y s  f o r  t h e  
nonsurvivor group and 5.8±7.7 days for the survivor group, but 
the  difference  was  statistically  insignificant.  There  was  no 
significant  difference  for  the  changes  of  the  serum  levels  of 
creatinine  and  urea  after  RRT  between  the  2  groups,  but  the 
serum  bicarbonate  level  was  significantly  lower  for  the 
nonsurvivor group than for the survivor group (16.4±5.4 mmol/L 
vs.  21.4±3.5  mmol/L,  respectively;  p<0.05).
On the multivariate analysis of the contributory factors for the 
mortality rate, the serum albumin level and the mean ABP values 
measured  before  and  the  day  after  RRT  and  the  serum 
bicarbonate level measured the day after RRT were significantly 
lower.  However,  on  logistic  regression  analysis,  the  mean  ABP 
and  the  serum  bicarbonate  level  were  the  important  factors  for 
the  mortality  rate  (Table  3).
For  the  stage  3  subgroup,  the  mortality  rate,  the  SAPS  II   
scores  and  the  serum  levels  of  urea  and  creatinine  were 
s i g n i f i c a n t l y  h i g h e r  f o r  t h e  s t a g e  3  s u b g r o u p ,  a n d  t h e  s e r u m  Variable cOR  (95%  CI) p-value aOR  (95%  CI) p-value
Albumin 0.44  (0.23-0.83) p<0.05 0.54  (0.23-1.26) NS
M e a n  b l o o d  p r e s s u r e  ( m m H g )  1  d a y  a f t e r  t h e  
initiation  of  CRRT
0.96  (0.94-0.98) p<0.05 0.97  (0.95-1.00) p<0.05
HCO3
- ( m m o l / L )  1  d a y  a f t e r  t h e  i n i t i a t i o n  o f  
CRRT
0.80  (0.72-0.88) p<0.05 0.83  (0.74-0.93) p<0.05
CRRT,  continuous  renal  replacement  therapy
Table  3.  The  unadjusted  and  adjusted  predictors  of  survival
Tatal Stage  1 Stage  2 Stage  3 p-value
No.  of  patients
No.of  pateints
(%  mortality  rate)
SAPS  II  score
M e a n  b l o o d  p r e s s u r e  ( m m H g )
BUN  (mg/dL)
Creatiine  (mg/dL)
Albumin  (g/dL)
HCO3-  (mmol/L)  1day  after  CRRT
M e a n  b l o o d  p r e s s u r e  ( m m H g )  1 d a y  a f t e r  C R R T
118
72/118 
(61%)
61.1±16.1
77.2±19.0
70.2±39.9
4.5±2.6
2.8±0.6
18.3±5.3
75.6±25.9
11  (9.3%)
1/11 
(9.1%)
50.0±12.4
93.5±19.3
45.0±19.1
3.0±1.8
3.3±0.5
21.7±4.4
97.5±7.4
29  (24.6%)
16/29 
(55.2%)
61.3±19.1
83.4±21.3
58.5±31.9
3.0±1.2
2.9±0.6
18.8±5.4
71.8±30.5
78  (66.1%)
55/78 
(70.5%)
62.7±14.9
72.6±16.2
78.0±42.4
5.2±2.8
2.7±0.5
17.8±5.2
73.9±24.5
p<0.05
p<0.05
p<0.05
NS
p<0.05
p<0.05
NS
p<0.05
SAPS,  simplified  acute  physiology  score;  BUN,  blood  urea  nitrogen;  CRRT,  continuous  renal  replacement  therapy
Table  4.  The  outcomes  based  on  the  acute  kidney  injury  classification
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Figure.  Kaplan  Meier  estimation  of  the  survival  rates  for  the  three 
groups  (Log-rank  test:  p<0.05).
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levels of albumin and bicarbonate tended to be lower (Table 4).
The  mortality  rate  was  90.9%  for  the  stage  1  subgroup, 
44.8%  for  the  stage  2  subgroup  and  29.5%  for  the  stage  3 
subgroup, and so the mortality rate was lowest for the stage 3 
subgroup  (Figure).
DISCUSSION
Although  there  is  still  no  concordance  between  studies 
regarding  the  definition,  treatment  modalities  and  treatment 
outcomes of AKI, its mortality rate has been reduced because of 
the successful treatment of acute renal failure via dialysis
9). Since 
Kramer  et  al.
10) f i r s t  d e s c r i b e d  c o n t i n u o u s  a r t e r i o v e n o u s  
h e m o f i l t r a t i o n  ( C A V H )  i n  1 9 7 7 ,  C R R T  s u c h  a s  c o n t i n u o u s  
venovenous  hemodiafiltration  (CVVHDF)  has  been  developed 
along with countermeasures for correcting its shortcomings and 
CRRT has been widely used in clinical settings. CRRT can lead 
to  a  normal  equilibrium  of  electrolytes  and  a  normal  acid  base 
balance,  as  well  as  hemodynamic  stability,  and  it  may  be 
effective  for  the  treatment  of  patients  with  brain  edema. 
H o w e v e r ,  d e s p i t e  t h e s e  t h e r a p e u t i c  e f f e c t s ,  i t  i s  c o n t r o v e r s i a l  
whether  CRRT  is  better  than  intermittent  hemodialysis  for 
intensive  care
11).
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adequate  timing  of  RRT  and  the  clinical  characteristics  of  AKI. 
Although there is controversy concerning the adequate timing of 
RRT,  it  is  generally  recommended  that  RRT  should  be  initiated 
before the complications of AKI occur
12, 13).
  In the present study, 
RRT  was  performed  on  the  patients  who  were  admitted  to  the 
intensive  care  unit  due  to  AKI  associated  with  hemodynamic 
instability,  brain  edema,  a  high  catabolic  state  and  a  severe 
excess of body fluids, and their mortality rate was 61.0%, which 
was  similar  to  the  62.0%  mortality  rate  reported  by  a  previous 
study. The previous study also reported that the mortality rate of 
C R R T  i n c r e a s e d  f o r  t h e  c a s e s  w h e r e  t h e  d u r a t i o n  o f  t h i s  
treatment was long, oliguria was present and the renal functions 
were  reduced
15).  There  were  no  significant  differences  in  the 
mortality  rate  in  terms  of  the  blood  flow  rate,  the  amount  of 
ultrafiltrate,  the  duration  of  RRT  and  the  use  of  heparin  in  the 
present  study.  However,  since  the  mean  amount  of  ultrafiltrate 
was relatively low (18.7 mL/kg/min), it is thought that the survival 
r a t e  s h ou l d ha v e  be e n c ompa r e d wi t h t ha t  of  t he  pa t i e nt s  wi t h 
a  higher  amount  of  ultrafiltrate  (35  mL/kg/min).  In  our  study, 
there  was  no  significant  association  between  the  mortality  rate 
and oliguria, the RRT outcomes or renal functions. The mortality 
rate  tended  to  become  high  for  the  cases  where  the  serum 
C-reactive protein was increased, the mean ABP was decreased 
before the start of dialysis and the serum bicarbonate level was 
decreased  the  day  after  dialysis.  The  mortality  rate  was 
significantly  higher  for  the  cases  where  the  mean  ABP  and  the 
serum  bicarbonate  level  decreased  the  day  after  RRT.  It  has 
been reported that there is a high mortality rate when the mean 
ABP bef ore RRT i s  l ow and t he bl ood pres sur e i s l ow 2 hours 
after  RRT
14).  In  the  present  study,  since  the  patients  who  were 
undergoing  RRT  were  hemodynamically  unstable,  they  showed 
remarkable  changes  in  blood  pressure  on  the  day  of  RRT; 
however, their blood pressure was stabilized the day after RRT. 
Although  the  blood  pressures  before  RRT,  2  hours  after  RRT 
and the day after RRT were related to the mortality rate, only the 
blood pressure measured the day after RRT showed a significant 
correlation  with  the  mortality  rate.  The  blood  pressure  and  the 
serum  bicarbonate  level  were  significantly  correlated  with  the 
mortality  rate,  which  indicates  that  rapid  restoration  of 
hemodynamic stability and recovery from metabolic acidosis may 
be important factors for the mortality rate for patients with AKI. 
Wald  et al
15)  has  reported  that  CRRT  results  in  a  low  mortality 
rate through the restoration of hemodynamic stability and normal 
kidney functioning. The results of the present study indicate that 
the  mortality  rate  is  low  for  the  cases  where  the  mean  ABP  is 
high. This may be explained by the restoration of hemodynamic 
stability,  which  is  one  of  the  therapeutic  effects  of  CRRT. 
  Since  the  prognosis  of  AKI  is  affected  by  numerous 
variables,  its  prediction  and  making  precise  comparisons  of  the 
accuracy  between  the  prognostic  factors  are  difficult.  Various 
studies  have  compared  prognostic  factors  with  using  the  risk, 
injury,  failure  loss  and  end  kidney  disease  (RIFLE)  classification, 
the  acute  physiology  and  chronic  health  evaluation  (APAHE)  II 
s c o r i n g  s y s t e m ,  t h e  S A P S  I I  s c o r i n g  s y s t e m ,  t h e  m o r t a l i t y  
prediction  model  (MPM),  the  sepsis-related  organ  assessment 
( S O F A )  a n d  t h e  l o g i s t i c  o r g a n  d y s f u n c t i o n  s y s t e m  ( L O D S )
16, 17). 
In particular, since a review of the literature does not yield  a 
consensus  about  the  definition  and  classification  of  AKI,  there 
remain  some  difficulties  for  conducting  research  and  improving 
the prognosis. In the present study, the usefulness of the SAPS 
II scoring system and the classification proposed in 2007 by the 
Acute  Dialysis  Quality  Initiative  (ADQI)  group
8)  was  evaluated  for 
the  patients  who  underwent  CRRT.  The  stage  3  AKI  subgroup 
showed the highest mortality rate (70.5%) and the highest SAPS 
I I  s c o r e  ( 6 2 . 7 ± 1 4 . 9 ) ,  w h i c h  w a s  s i m i l a r  t o  t h e  r e s u l t s  o f  a  
previous  study  that  the  renal  failure  group  according  to  the 
R I F L E  c l a s s i f i c a t i o n  s h o w e d  t h e  h i g h e s t  m o r t a l i t y  r a t e  ( 7 4 . 4 % )  
and  the  highest  SAPS  II  score  (55.9±2.7)
16).
  Based  on  the 
r e s u l t s  t h a t  t h e  s t a g e  3  A K I  s u b g r o u p ,  w h i c h  w a s  t h e  m o s t  
severe group and it exhibited the highest mortality rate, we think 
that the severity of AKI may affect the prognosis of AKI patients. 
Kresse  et  al
18)  have  reported  that  for  patients  with  AKI,  the 
mortality rate increases as the severity of the underlying diseases 
become  more  severe.  It  has  been  demonstrated  that  the 
APACHE  II  scores  sensitively  reflect  the  mortality  rate  for  the 
injury  group,  whereas  the  SAPS  II  scores  sensitively  reflect  the 
m o r t a l i t y  r a t e  f o r  t h e  h i g h  r i s k  a n d  s e v e r e  i n j u r y  g r o u p s .  F o r  
these reasons, we evaluated the severity of the patients with AKI 
b y  u s i n g  t h e  S A P S  I I  s c o r i n g  s y s t e m .  A l t h o u g h  t h e r e  w a s  n o  
significant difference of the SAPS II scores between the survivor 
and  nonsurvivor  groups,  the  SAPS  II  scores  were  significantly 
i n c r e a s e d  f o r  t h e  s t a g e  3  A K I  s u b g r o u p ,  s u g g e s t i n g  t h a t  t h e  
SAPS  II  scoring  system  can  be  used  along  with  the  AKI 
classification  system  for  evaluating  the  severity  of  AKI.
I n  c o n c l u s i o n ,  t h e  m o s t  i m p o r t a n t  p r o g n o s t i c  f a c t o r  f o r  A K I  
patients  may  be  the  hemodynamic  status,  and  especially  the 
blood  pressure  or  the  serum  bicarbonate  level  after  undergoing 
CRRT.  The  AKI  classification  and  the  SAPS  II  scoring  system 
can  help  evaluate  the  severity  of  AKI,  which  suggests  that  the 
general status of patients and the severity of AKI may be more 
important  for  the  prognosis  than  the  CRRT  itself. 
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